Alpa Laboratories Ltd Nine Monthly Results

Gross Sales

72.53

85.13

63.28

87.1

72.57

Excise Duty

0

0

0

0

0

Net Sales

72.53

85.13

63.28

87.1

72.57

Other Operating Income

0

0

0

0

0

Other Income

20.87

10.92

10.62

9.14

3.73

Total Income

93.4

96.06

73.9

96.24

76.3

Total Expenditure

67.94

80.53

64.93

77.31

66.09

PBIDT

25.46

15.52

8.96

18.93

10.21

Interest

0.19

0.06

0.19

0.19

0.07

PBDT

25.27

15.46

8.78

18.74

10.15

Depreciation

1.62

1.43

0.8

1.16

0.88

Minority Interest Before NP

0

0

0

0

0

Tax

1.97

0

0

0

0

Deferred Tax

0

0.79

0

0

0

Reported Profit After Tax

21.68

13.24

7.98

17.58

9.27

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

21.68

13.24

7.98

17.58

9.27

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

21.68

13.24

7.98

17.58

9.27

EPS (Unit Curr.)

10.31

6.31

3.8

8.36

4.41

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

21.04

21.04

21.04

21.04

21.04

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.1

18.23

14.15

21.73

14.06

PBDTM(%)

34.84

18.16

13.87

21.51

13.98

PATM(%)

29.89

15.55

12.61

20.18

12.77